0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Testing Using PCR for IVD Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-15X9418
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Infectious Disease Testing Using PCR for IVD Market Insights and Forecast to 2028
BUY CHAPTERS

Global Infectious Disease Testing Using PCR for IVD Market Research Report 2024

Code: QYRE-Auto-15X9418
Report
January 2024
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Disease Testing Using PCR for IVD Market

The introduction of available in vitro diagnostic (IVD) PCR assays into the clinical microbiology laboratory has facilitated enhancements to patient care, improving diagnostic sensitivity and specificity.
The global Infectious Disease Testing Using PCR for IVD market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Disease Testing Using PCR for IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Disease Testing Using PCR for IVD is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Infectious Disease Testing Using PCR for IVD include Thermo Fisher, BD, Roche Diagnostics, Merck, Siemens Healthineers, Hologic, Abbott Laboratories, BioMerieux and Cepheid, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Testing Using PCR for IVD, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Testing Using PCR for IVD.

Report Scope

The Infectious Disease Testing Using PCR for IVD market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Testing Using PCR for IVD market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Testing Using PCR for IVD manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease Testing Using PCR for IVD Market Report

Report Metric Details
Report Name Infectious Disease Testing Using PCR for IVD Market
Segment by Type
  • Direct Detection
  • Indirect Detection
Segment by Application
  • Hospitals
  • Laboratory
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, BD, Roche Diagnostics, Merck, Siemens Healthineers, Hologic, Abbott Laboratories, BioMerieux, Cepheid, Bayer, Sysmex, Ortho Clinical Diagnostics, Qiagen, Codexis, Bio-Rad Laboratories, Oxford Nanopore
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Infectious Disease Testing Using PCR for IVD manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Infectious Disease Testing Using PCR for IVD in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Infectious Disease Testing Using PCR for IVD Market report?

Ans: The main players in the Infectious Disease Testing Using PCR for IVD Market are Thermo Fisher, BD, Roche Diagnostics, Merck, Siemens Healthineers, Hologic, Abbott Laboratories, BioMerieux, Cepheid, Bayer, Sysmex, Ortho Clinical Diagnostics, Qiagen, Codexis, Bio-Rad Laboratories, Oxford Nanopore

What are the Application segmentation covered in the Infectious Disease Testing Using PCR for IVD Market report?

Ans: The Applications covered in the Infectious Disease Testing Using PCR for IVD Market report are Hospitals, Laboratory, Other

What are the Type segmentation covered in the Infectious Disease Testing Using PCR for IVD Market report?

Ans: The Types covered in the Infectious Disease Testing Using PCR for IVD Market report are Direct Detection, Indirect Detection

1 Infectious Disease Testing Using PCR for IVD Market Overview
1.1 Product Overview and Scope of Infectious Disease Testing Using PCR for IVD
1.2 Infectious Disease Testing Using PCR for IVD Segment by Type
1.2.1 Global Infectious Disease Testing Using PCR for IVD Market Value Comparison by Type (2024-2030)
1.2.2 Direct Detection
1.2.3 Indirect Detection
1.3 Infectious Disease Testing Using PCR for IVD Segment by Application
1.3.1 Global Infectious Disease Testing Using PCR for IVD Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Other
1.4 Global Infectious Disease Testing Using PCR for IVD Market Size Estimates and Forecasts
1.4.1 Global Infectious Disease Testing Using PCR for IVD Revenue 2019-2030
1.4.2 Global Infectious Disease Testing Using PCR for IVD Sales 2019-2030
1.4.3 Global Infectious Disease Testing Using PCR for IVD Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Infectious Disease Testing Using PCR for IVD Market Competition by Manufacturers
2.1 Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Manufacturers (2019-2024)
2.2 Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Infectious Disease Testing Using PCR for IVD Average Price by Manufacturers (2019-2024)
2.4 Global Infectious Disease Testing Using PCR for IVD Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infectious Disease Testing Using PCR for IVD, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infectious Disease Testing Using PCR for IVD, Product Type & Application
2.7 Infectious Disease Testing Using PCR for IVD Market Competitive Situation and Trends
2.7.1 Infectious Disease Testing Using PCR for IVD Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Infectious Disease Testing Using PCR for IVD Players Market Share by Revenue
2.7.3 Global Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Infectious Disease Testing Using PCR for IVD Retrospective Market Scenario by Region
3.1 Global Infectious Disease Testing Using PCR for IVD Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Infectious Disease Testing Using PCR for IVD Global Infectious Disease Testing Using PCR for IVD Sales by Region: 2019-2030
3.2.1 Global Infectious Disease Testing Using PCR for IVD Sales by Region: 2019-2024
3.2.2 Global Infectious Disease Testing Using PCR for IVD Sales by Region: 2025-2030
3.3 Global Infectious Disease Testing Using PCR for IVD Global Infectious Disease Testing Using PCR for IVD Revenue by Region: 2019-2030
3.3.1 Global Infectious Disease Testing Using PCR for IVD Revenue by Region: 2019-2024
3.3.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Region: 2025-2030
3.4 North America Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.4.1 North America Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.4.3 North America Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.5.1 Europe Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.5.3 Europe Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.6.1 Asia Pacific Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.6.3 Asia Pacific Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.7.1 Latin America Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.7.3 Latin America Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Infectious Disease Testing Using PCR for IVD Market Facts & Figures by Country
3.8.1 Middle East and Africa Infectious Disease Testing Using PCR for IVD Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2030)
3.8.3 Middle East and Africa Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Infectious Disease Testing Using PCR for IVD Sales by Type (2019-2030)
4.1.1 Global Infectious Disease Testing Using PCR for IVD Sales by Type (2019-2024)
4.1.2 Global Infectious Disease Testing Using PCR for IVD Sales by Type (2025-2030)
4.1.3 Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Type (2019-2030)
4.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2019-2030)
4.2.1 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2019-2024)
4.2.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2025-2030)
4.2.3 Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type (2019-2030)
4.3 Global Infectious Disease Testing Using PCR for IVD Price by Type (2019-2030)
5 Segment by Application
5.1 Global Infectious Disease Testing Using PCR for IVD Sales by Application (2019-2030)
5.1.1 Global Infectious Disease Testing Using PCR for IVD Sales by Application (2019-2024)
5.1.2 Global Infectious Disease Testing Using PCR for IVD Sales by Application (2025-2030)
5.1.3 Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Application (2019-2030)
5.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Application (2019-2030)
5.2.1 Global Infectious Disease Testing Using PCR for IVD Revenue by Application (2019-2024)
5.2.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Application (2025-2030)
5.2.3 Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Application (2019-2030)
5.3 Global Infectious Disease Testing Using PCR for IVD Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Infectious Disease Testing Using PCR for IVD Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 BD
6.2.1 BD Corporation Information
6.2.2 BD Description and Business Overview
6.2.3 BD Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Infectious Disease Testing Using PCR for IVD Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Diagnostics Infectious Disease Testing Using PCR for IVD Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Infectious Disease Testing Using PCR for IVD Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Siemens Healthineers
6.5.1 Siemens Healthineers Corporation Information
6.5.2 Siemens Healthineers Description and Business Overview
6.5.3 Siemens Healthineers Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Siemens Healthineers Infectious Disease Testing Using PCR for IVD Product Portfolio
6.5.5 Siemens Healthineers Recent Developments/Updates
6.6 Hologic
6.6.1 Hologic Corporation Information
6.6.2 Hologic Description and Business Overview
6.6.3 Hologic Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hologic Infectious Disease Testing Using PCR for IVD Product Portfolio
6.6.5 Hologic Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Infectious Disease Testing Using PCR for IVD Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 BioMerieux
6.8.1 BioMerieux Corporation Information
6.8.2 BioMerieux Description and Business Overview
6.8.3 BioMerieux Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioMerieux Infectious Disease Testing Using PCR for IVD Product Portfolio
6.8.5 BioMerieux Recent Developments/Updates
6.9 Cepheid
6.9.1 Cepheid Corporation Information
6.9.2 Cepheid Description and Business Overview
6.9.3 Cepheid Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cepheid Infectious Disease Testing Using PCR for IVD Product Portfolio
6.9.5 Cepheid Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer Infectious Disease Testing Using PCR for IVD Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Sysmex
6.11.1 Sysmex Corporation Information
6.11.2 Sysmex Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.11.3 Sysmex Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sysmex Infectious Disease Testing Using PCR for IVD Product Portfolio
6.11.5 Sysmex Recent Developments/Updates
6.12 Ortho Clinical Diagnostics
6.12.1 Ortho Clinical Diagnostics Corporation Information
6.12.2 Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.12.3 Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Product Portfolio
6.12.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.13 Qiagen
6.13.1 Qiagen Corporation Information
6.13.2 Qiagen Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.13.3 Qiagen Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Qiagen Infectious Disease Testing Using PCR for IVD Product Portfolio
6.13.5 Qiagen Recent Developments/Updates
6.14 Codexis
6.14.1 Codexis Corporation Information
6.14.2 Codexis Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.14.3 Codexis Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Codexis Infectious Disease Testing Using PCR for IVD Product Portfolio
6.14.5 Codexis Recent Developments/Updates
6.15 Bio-Rad Laboratories
6.15.1 Bio-Rad Laboratories Corporation Information
6.15.2 Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.15.3 Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Product Portfolio
6.15.5 Bio-Rad Laboratories Recent Developments/Updates
6.16 Oxford Nanopore
6.16.1 Oxford Nanopore Corporation Information
6.16.2 Oxford Nanopore Infectious Disease Testing Using PCR for IVD Description and Business Overview
6.16.3 Oxford Nanopore Infectious Disease Testing Using PCR for IVD Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Oxford Nanopore Infectious Disease Testing Using PCR for IVD Product Portfolio
6.16.5 Oxford Nanopore Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infectious Disease Testing Using PCR for IVD Industry Chain Analysis
7.2 Infectious Disease Testing Using PCR for IVD Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infectious Disease Testing Using PCR for IVD Production Mode & Process
7.4 Infectious Disease Testing Using PCR for IVD Sales and Marketing
7.4.1 Infectious Disease Testing Using PCR for IVD Sales Channels
7.4.2 Infectious Disease Testing Using PCR for IVD Distributors
7.5 Infectious Disease Testing Using PCR for IVD Customers
8 Infectious Disease Testing Using PCR for IVD Market Dynamics
8.1 Infectious Disease Testing Using PCR for IVD Industry Trends
8.2 Infectious Disease Testing Using PCR for IVD Market Drivers
8.3 Infectious Disease Testing Using PCR for IVD Market Challenges
8.4 Infectious Disease Testing Using PCR for IVD Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Infectious Disease Testing Using PCR for IVD Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Infectious Disease Testing Using PCR for IVD Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Infectious Disease Testing Using PCR for IVD Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Infectious Disease Testing Using PCR for IVD Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Infectious Disease Testing Using PCR for IVD Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Infectious Disease Testing Using PCR for IVD Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Infectious Disease Testing Using PCR for IVD Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Infectious Disease Testing Using PCR for IVD, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Infectious Disease Testing Using PCR for IVD, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Infectious Disease Testing Using PCR for IVD, Product Type & Application
    Table 12. Global Key Manufacturers of Infectious Disease Testing Using PCR for IVD, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Infectious Disease Testing Using PCR for IVD by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing Using PCR for IVD as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Infectious Disease Testing Using PCR for IVD Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Infectious Disease Testing Using PCR for IVD Sales by Region (2019-2024) & (K Units)
    Table 18. Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Region (2019-2024)
    Table 19. Global Infectious Disease Testing Using PCR for IVD Sales by Region (2025-2030) & (K Units)
    Table 20. Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Region (2025-2030)
    Table 21. Global Infectious Disease Testing Using PCR for IVD Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Region (2019-2024)
    Table 23. Global Infectious Disease Testing Using PCR for IVD Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Region (2025-2030)
    Table 25. North America Infectious Disease Testing Using PCR for IVD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2024) & (K Units)
    Table 27. North America Infectious Disease Testing Using PCR for IVD Sales by Country (2025-2030) & (K Units)
    Table 28. North America Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Infectious Disease Testing Using PCR for IVD Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Infectious Disease Testing Using PCR for IVD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Infectious Disease Testing Using PCR for IVD Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Infectious Disease Testing Using PCR for IVD Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Infectious Disease Testing Using PCR for IVD Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Infectious Disease Testing Using PCR for IVD Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Infectious Disease Testing Using PCR for IVD Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Infectious Disease Testing Using PCR for IVD Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Infectious Disease Testing Using PCR for IVD Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Infectious Disease Testing Using PCR for IVD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Infectious Disease Testing Using PCR for IVD Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Infectious Disease Testing Using PCR for IVD Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Infectious Disease Testing Using PCR for IVD Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Infectious Disease Testing Using PCR for IVD Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Infectious Disease Testing Using PCR for IVD Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Infectious Disease Testing Using PCR for IVD Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Infectious Disease Testing Using PCR for IVD Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Infectious Disease Testing Using PCR for IVD Sales (K Units) by Type (2019-2024)
    Table 51. Global Infectious Disease Testing Using PCR for IVD Sales (K Units) by Type (2025-2030)
    Table 52. Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Type (2019-2024)
    Table 53. Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Type (2025-2030)
    Table 54. Global Infectious Disease Testing Using PCR for IVD Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Infectious Disease Testing Using PCR for IVD Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type (2019-2024)
    Table 57. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Type (2025-2030)
    Table 58. Global Infectious Disease Testing Using PCR for IVD Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Infectious Disease Testing Using PCR for IVD Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Infectious Disease Testing Using PCR for IVD Sales (K Units) by Application (2019-2024)
    Table 61. Global Infectious Disease Testing Using PCR for IVD Sales (K Units) by Application (2025-2030)
    Table 62. Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Application (2019-2024)
    Table 63. Global Infectious Disease Testing Using PCR for IVD Sales Market Share by Application (2025-2030)
    Table 64. Global Infectious Disease Testing Using PCR for IVD Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Infectious Disease Testing Using PCR for IVD Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Application (2019-2024)
    Table 67. Global Infectious Disease Testing Using PCR for IVD Revenue Market Share by Application (2025-2030)
    Table 68. Global Infectious Disease Testing Using PCR for IVD Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Infectious Disease Testing Using PCR for IVD Price (USD/Unit) by Application (2025-2030)
    Table 70. Thermo Fisher Corporation Information
    Table 71. Thermo Fisher Description and Business Overview
    Table 72. Thermo Fisher Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Thermo Fisher Infectious Disease Testing Using PCR for IVD Product
    Table 74. Thermo Fisher Recent Developments/Updates
    Table 75. BD Corporation Information
    Table 76. BD Description and Business Overview
    Table 77. BD Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. BD Infectious Disease Testing Using PCR for IVD Product
    Table 79. BD Recent Developments/Updates
    Table 80. Roche Diagnostics Corporation Information
    Table 81. Roche Diagnostics Description and Business Overview
    Table 82. Roche Diagnostics Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Roche Diagnostics Infectious Disease Testing Using PCR for IVD Product
    Table 84. Roche Diagnostics Recent Developments/Updates
    Table 85. Merck Corporation Information
    Table 86. Merck Description and Business Overview
    Table 87. Merck Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Merck Infectious Disease Testing Using PCR for IVD Product
    Table 89. Merck Recent Developments/Updates
    Table 90. Siemens Healthineers Corporation Information
    Table 91. Siemens Healthineers Description and Business Overview
    Table 92. Siemens Healthineers Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Siemens Healthineers Infectious Disease Testing Using PCR for IVD Product
    Table 94. Siemens Healthineers Recent Developments/Updates
    Table 95. Hologic Corporation Information
    Table 96. Hologic Description and Business Overview
    Table 97. Hologic Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Hologic Infectious Disease Testing Using PCR for IVD Product
    Table 99. Hologic Recent Developments/Updates
    Table 100. Abbott Laboratories Corporation Information
    Table 101. Abbott Laboratories Description and Business Overview
    Table 102. Abbott Laboratories Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Abbott Laboratories Infectious Disease Testing Using PCR for IVD Product
    Table 104. Abbott Laboratories Recent Developments/Updates
    Table 105. BioMerieux Corporation Information
    Table 106. BioMerieux Description and Business Overview
    Table 107. BioMerieux Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. BioMerieux Infectious Disease Testing Using PCR for IVD Product
    Table 109. BioMerieux Recent Developments/Updates
    Table 110. Cepheid Corporation Information
    Table 111. Cepheid Description and Business Overview
    Table 112. Cepheid Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Cepheid Infectious Disease Testing Using PCR for IVD Product
    Table 114. Cepheid Recent Developments/Updates
    Table 115. Bayer Corporation Information
    Table 116. Bayer Description and Business Overview
    Table 117. Bayer Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Bayer Infectious Disease Testing Using PCR for IVD Product
    Table 119. Bayer Recent Developments/Updates
    Table 120. Sysmex Corporation Information
    Table 121. Sysmex Description and Business Overview
    Table 122. Sysmex Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Sysmex Infectious Disease Testing Using PCR for IVD Product
    Table 124. Sysmex Recent Developments/Updates
    Table 125. Ortho Clinical Diagnostics Corporation Information
    Table 126. Ortho Clinical Diagnostics Description and Business Overview
    Table 127. Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. Ortho Clinical Diagnostics Infectious Disease Testing Using PCR for IVD Product
    Table 129. Ortho Clinical Diagnostics Recent Developments/Updates
    Table 130. Qiagen Corporation Information
    Table 131. Qiagen Description and Business Overview
    Table 132. Qiagen Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 133. Qiagen Infectious Disease Testing Using PCR for IVD Product
    Table 134. Qiagen Recent Developments/Updates
    Table 135. Codexis Corporation Information
    Table 136. Codexis Description and Business Overview
    Table 137. Codexis Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 138. Codexis Infectious Disease Testing Using PCR for IVD Product
    Table 139. Codexis Recent Developments/Updates
    Table 140. Bio-Rad Laboratories Corporation Information
    Table 141. Bio-Rad Laboratories Description and Business Overview
    Table 142. Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 143. Bio-Rad Laboratories Infectious Disease Testing Using PCR for IVD Product
    Table 144. Bio-Rad Laboratories Recent Developments/Updates
    Table 145. Oxford Nanopore Corporation Information
    Table 146. Oxford Nanopore Description and Business Overview
    Table 147. Oxford Nanopore Infectious Disease Testing Using PCR for IVD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 148. Oxford Nanopore Infectious Disease Testing Using PCR for IVD Product
    Table 149. Oxford Nanopore Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Infectious Disease Testing Using PCR for IVD Distributors List
    Table 153. Infectious Disease Testing Using PCR for IVD Customers List
    Table 154. Infectious Disease Testing Using PCR for IVD Market Trends
    Table 155. Infectious Disease Testing Using PCR for IVD Market Drivers
    Table 156. Infectious Disease Testing Using PCR for IVD Market Challenges
    Table 157. Infectious Disease Testing Using PCR for IVD Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Infectious Disease Testing Using PCR for IVD
    Figure 2. Global Infectious Disease Testing Using PCR for IVD Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Infectious Disease Testing Using PCR for IVD Market Share by Type in 2023 & 2030
    Figure 4. Direct Detection Product Picture
    Figure 5. Indirect Detection Product Picture
    Figure 6. Global Infectious Disease Testing Using PCR for IVD Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Infectious Disease Testing Using PCR for IVD Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Laboratory
    Figure 10. Other
    Figure 11. Global Infectious Disease Testing Using PCR for IVD Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Infectious Disease Testing Using PCR for IVD Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Infectious Disease Testing Using PCR for IVD Sales (2019-2030) & (K Units)
    Figure 14. Global Infectious Disease Testing Using PCR for IVD Average Price (USD/Unit) & (2019-2030)
    Figure 15. Infectious Disease Testing Using PCR for IVD Report Years Considered
    Figure 16. Infectious Disease Testing Using PCR for IVD Sales Share by Manufacturers in 2023
    Figure 17. Global Infectious Disease Testing Using PCR for IVD Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Infectious Disease Testing Using PCR for IVD Players: Market Share by Revenue in 2023
    Figure 19. Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Infectious Disease Testing Using PCR for IVD Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Infectious Disease Testing Using PCR for IVD Sales Market Share by Country (2019-2030)
    Figure 22. North America Infectious Disease Testing Using PCR for IVD Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Infectious Disease Testing Using PCR for IVD Sales Market Share by Country (2019-2030)
    Figure 26. Europe Infectious Disease Testing Using PCR for IVD Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Infectious Disease Testing Using PCR for IVD Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Infectious Disease Testing Using PCR for IVD Revenue Market Share by Region (2019-2030)
    Figure 34. China Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Infectious Disease Testing Using PCR for IVD Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Infectious Disease Testing Using PCR for IVD Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Infectious Disease Testing Using PCR for IVD Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Infectious Disease Testing Using PCR for IVD Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. U.A.E Infectious Disease Testing Using PCR for IVD Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Infectious Disease Testing Using PCR for IVD by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Infectious Disease Testing Using PCR for IVD by Type (2019-2030)
    Figure 56. Global Infectious Disease Testing Using PCR for IVD Price (USD/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Infectious Disease Testing Using PCR for IVD by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Infectious Disease Testing Using PCR for IVD by Application (2019-2030)
    Figure 59. Global Infectious Disease Testing Using PCR for IVD Price (USD/Unit) by Application (2019-2030)
    Figure 60. Infectious Disease Testing Using PCR for IVD Value Chain
    Figure 61. Infectious Disease Testing Using PCR for IVD Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS